研究报告 |
|
|
|
|
一种新型的截短型转化生长因子βⅡ型受体在大肠杆菌中的表达及活性鉴定 |
初彦辉1,刘海峰2,王小花3,张羽飞3,武艳3,袁晓环3 |
1. 牡丹江医学院黑龙江省抗纤维化生物治疗重点实验室 牡丹江 157011
2. 暨南大学生命科学与技术学院 广州 5106323
3.牡丹江医学院病原生物学实验室 牡丹江 157011 |
|
Expression and Characterization of a Novel Truncated TGF-&beta|Receptor II Synthesized in Escherichia coli |
CHU Pan-Hui1,2**, LIU Hai-Feng1, WANG Xiao-Hua3, ZHANG Hu-Fei1, WU Yan1, YUAN Xiao-Huan1 |
1.Heilongjiang Key Laboratory of Antifibrosis Biotherapy, Mu Dan Jiang Medical University, Mudanjiang157011, China
2.College of Life Science and Technology, Jinan University, Guangzhou510632,China
3.The Laboratory of Pathogeny Biology, Mu Dan Jiang Medical University, Mudanjiang157011, China |
引用本文:
初彦辉,刘海峰,王小花,张羽飞,武艳,袁晓环. 一种新型的截短型转化生长因子βⅡ型受体在大肠杆菌中的表达及活性鉴定[J]. 中国生物工程杂志, 2009, 29(08): 33-37.
CHU Pan-Hui, LIU Hai-Feng, WANG Xiao-Hua, ZHANG Hu-Fei, WU Yan, YUAN Xiao-Huan. Expression and Characterization of a Novel Truncated TGF-&beta|Receptor II Synthesized in Escherichia coli. China Biotechnology, 2009, 29(08): 33-37.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2009/V29/I08/33
|
[1] Gordon K J, Blobe G C. Role of transforming growth factor β in human disease.Biochim Biophys Acta,2008, 1782(4):197~228
[2] Singer A J, Clark RA. Cutaneous wound healing.N Engl J Med,1999,341(10):738~746
[3] Cold L I,Sung J J, Siebert J W,et al. TypeⅠ(RⅠ) and type Ⅱ(RⅡ) receptors for transf orming growth factorβ isoforms are expressed subsequent to transforming factorβ ligands during excisional wound repair.Am J Pathol,1997,150(1):209~222
[4] Horner A, Kemp P, Summers C, et al. Expression and distribution of transforming growth factorbeta isoforms and their signaling receptors in growing human bone.Bone,1998 ,23(2):95~102
[5] Wieser R, Attisano L, Wrana J L, et al. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region.Mol Cell Biol,1993,13(12):7239~7247
[6] Carcamo J, Zentella A, Massague J. Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol Cell Biol,1995,15(3):1573~1581
[7] VermaGandhu M, Peterson M R, Peterson T C, et al. Effect of fetuin, a TGF β antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis. Eur J Pharmacol, 2007,572(23):220~227
[8] Li P, Suzanne O, Lea N, et al. ANP signaling inhibits TGFβinduced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells.J Appl Physiol,2007,102(1):390~398
[9] Shibuya H, Yamaguchi K, Shirakabe K, et al. TAB1: An activator of TAK1 MAPKKK in TGFβ signal transduction.Science,1996, 272(2):1179~1182
[10] Choi B M, Kwak I J, Jun C D,et al. Control of scaring in adult wounds using antisense transforming growth factor beta l oligo deoxynucleotides .Immunol Cell Biol,1996,74(2)144~150
[11] Wang X, Smith P, Pu LL, et al. Exogenous transforming growth factorbeta modulates collagen Ⅰand collagen Ⅱsynthesis in proliferative xenografts in nude rats. J Surg Res,1999,87(2):194~200
[12] 赵自然,刘鹤松,路来金.转化生长因子β与瘢痕形成和创伤愈合,深圳中西医结合杂志. 2004,14(1):57~59
Zhao Z R, Liu H S, Lu L J.Shenzhen Journal of Integrated Traditional Chinese and Western Medicine,2004,14(1):57~59
[13] Liu W, Chin C S, Lisu B A, et al. Blocking transformation growth factor beta I signaling downregulates TGFβlautocrine production and collagen gene expression in keloid fibroblasts. J Surgical Forum,2000,51:593~595 |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|